Company profile
Frost Biologic company profile
Frost Biologic operates in the biotechnology industry, focusing on the development of next-generation chemotherapeutics for cancer treatment. The company's lead program, FROST-450, is a small molecule inhibitor of microtubule polymerization, with a robust preclinical proof of concept. Frost Biologic also actively seeks new partnerships for the development of new molecules and ideas for clinical utility, particularly in cases that fall off the beaten path. The company's work is based on a licensed phenotypic screening technology used to identify compounds that can be optimized as small molecule cancer drugs.
Business identity
- Contact email
- [email protected]
- Phone number
- 1 801.664.7241
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2007-01-01
Headquarters
- Headquarters
- Shallowater, Texas, United States
- Country code
- US
- Continent
- North America